Ernest Mazzaferri Jr., MD, FACC, FSCAI is the Medical Director of The Ohio State University’s Richard M. Ross Heart Hospital and Associate Professor of Clinical Medicine in Cardiovascular Medicine at Ohio State's Wexner Medical Center.
Dr. Mazzaferri is a high volume interventional cardiologist who specializes in radial catheterization, is an active participant in the Transcatheter Aortic Valve Replacement (TAVR) program at Ohio State, and implanted the first Ventricular Partitioning Device (VPD) in the United States in March 2008. He also serves as Chairperson for the Central Ohio Mission Lifeline STEMI Accelerator Program, served a term on the American Heart Association's STEMI Science Advisory Task Force and Chaired the Mission Lifeline: Ohio Hospital Working group for many years. He received the Healthcare Heroes Award from Business First in 2009 for his work with The Ohio State University Medical Center's STEMI (ST Elevated Myocardial Infarction) program, as well as the 2013 Pulse of Columbus Award, and the 2013 Distinguished Service Award from the American Heart Association. Dr. Mazzaferri earned his medical degree and completed his residency at The Ohio State University College of Medicine, his general cardiology fellowship and chief Cardiology Fellowship at the University of Florida in Gainesville and interventional cardiology fellowship at Ohio State's Wexner Medical Center. An invited presenter on a variety of cardiovascular topics, Dr. Mazzaferri has published numerous abstracts, articles and book chapters. Dr. Mazzaferri has been on the faculty of multiple continuing medical education events, including Transcatheter Cardiovascular Therapeutics (TCT) and CSI and has served as the site Primary Investigator (PI) on numerous national trials while at the Wexner Medical Center.